Legal Representation
Attorney
Richard M. LaBarge
USPTO Deadlines
Next Deadline
1644 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240702)
Due Date
July 02, 2030
Grace Period Ends
January 02, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 2, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 2, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 16, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 16, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 27, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 9, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 14, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 14, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 14, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 6, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 6, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 6, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 26, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 28, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 16, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Antithrombotic drugs; thrombolytic drugs; Urokinase preparations for treating blood clots; Urokinase preparations for treating blood clots, administered intravenously; Urokinase preparations for clearing catheters and cannulas; Urokinase preparations for the restoration of patency to intravenous catheter, namely, central venous catheter, obstructed by clotted blood and fibrin; Urokinase preparations for treating pulmonary embolism; Urokinase preparations for treating the lysis of acute pulmonary emboli and pulmonary emboli accompanied by unstable hemodynamics; Urokinase preparations for treating thrombosis; Urokinase preparations for treating coronary artery thrombosis; Urokinase preparations for treating myocardial infarction; Urokinase preparations for the lysis of thrombi; Urokinase preparations for treating peripheral arterial and graft thromboembolic occlusion; Urokinase preparations for treating deep vein thrombosis; Urokinase preparations for treating pleural effusions; Urokinase preparations for treating peripheral arterial occlusion; Urokinase preparations for treating ischemic stroke; Urokinase preparations for treating lower limb ischemia
Classification
International Classes
005